Abdominal Radiology

, Volume 42, Issue 4, pp 1268–1275 | Cite as

Predictors of primary care provider adoption of CT colonography for colorectal cancer screening

  • Jennifer M. Weiss
  • David H. Kim
  • Maureen A. Smith
  • Aaron Potvien
  • Jessica R. Schumacher
  • Ronald E. Gangnon
  • B. Dustin Pooler
  • Patrick R. Pfau
  • Perry J. Pickhardt



To examine factors influencing primary care provider (PCP) adoption of CT colonography (CTC) for colorectal cancer (CRC) screening.

Materials and methods

We performed a retrospective cohort study linking electronic health record (EHR) data with PCP survey data. Patients were eligible for inclusion if they were not up-to-date with CRC screening and if they had CTC insurance coverage in the year prior to survey administration. PCPs were included if they had at least one eligible patient in their panel and completed the survey (final sample N = 95 PCPs; N = 6245 patients). Survey data included perceptions of CRC screening by any method, as well as CTC specifically. Multivariate logistic regression estimated odds ratios and 95% confidence intervals for PCP and clinic predictors of CRC screening by any method and screening with CTC.


Substantial variation in CTC use was seen among PCPs and clinics (range 0–16% of CRC screening). Predictors of higher CTC use were PCP perceptions that CTC is effective in reducing CRC mortality, higher number of perceived advantages to screening with CTC, and Internal Medicine specialty. Factors not associated with CTC use were PCP perceptions of less organizational capacity to meet demand for colonoscopy, number of perceived disadvantages to screening with CTC, PCP age and gender, and clinic factors.


Significant variation in PCP adoption of CTC exists. PCP perceptions of CTC and specialty practice were related to CTC adoption. Strategies to increase PCP adoption of CTC for CRC screening should include emphasis on the effectiveness and advantages of CTC.


Colorectal cancer screening CT colonography Primary care providers 


Compliance with ethical standards


This work was supported by the National Cancer Institute (Grants R01 CA144835 and P30 CA014520); the National Center for Advancing Translational Sciences (Grant UL1TR000427); the American Cancer Society (Grant MRSG-13-144-01-CPHPS); and the UW Health Innovation Program.

Conflict of interest

Perry J. Pickhardt is co-founder of VirtuoCTC and shareholder in SHINE, Elucent, and Cellectar Biosciences. David H. Kim is co-founder of VirtuoCTC, consultant for Viatronix, on the Medical Advisory Board for Digital ArtForms, and shareholder in Cellectar and Elucent. Patrick R. Pfau serves on the Scientific Advisory Board of Exact Sciences. The other authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Informed consent

Statement of informed consent was not applicable since the manuscript does not contain any patient data.


  1. 1.
    Zauber AG, Winawer SJ, O’Brien MJ, et al. (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687–696. doi: 10.1056/NEJMoa1100370 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Nishihara R, Wu K, Lochhead P, et al. (2013) Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369:1095–1105. doi: 10.1056/NEJMoa1301969 CrossRefPubMedGoogle Scholar
  3. 3.
    Lin JS, Piper MA, Perdue LA, et al. (2016) Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 315:2576–2594. doi: 10.1001/jama.2016.3332 CrossRefPubMedGoogle Scholar
  4. 4.
    Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA 66:7–30. doi: 10.3322/caac.21332 PubMedGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention (CDC) (2008) Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 57:253–258Google Scholar
  6. 6.
    The White House Cancer Moonshot Task Force (2016) Report of the Cancer Moonshot Task Force. https://www.whitehouse.gov/CancerMoonshot. Accessed October 19 2016
  7. 7.
    Inadomi JM, Vijan S, Janz NK, et al. (2012) Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172:575–582. doi: 10.1001/archinternmed.2012.332 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    DeBourcy AC, Lichtenberger S, Felton S, et al. (2008) Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23:169–174. doi: 10.1007/s11606-007-0480-1 CrossRefPubMedGoogle Scholar
  9. 9.
    Wong MCS, Ching JYL, Chan VCW, et al. (2014) Informed choice vs. no choice in colorectal cancer screening tests: a prospective cohort study in real-life screening practice. Am J Gastroenterol 109:1072–1079. doi: 10.1038/ajg.2014.136 CrossRefPubMedGoogle Scholar
  10. 10.
    Bibbins-Domingo K, Grossman DC, Curry SJ, et al. (2016) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315:2564–2575. doi: 10.1001/jama.2016.5989 CrossRefPubMedGoogle Scholar
  11. 11.
    Johnson CD, Chen MH, Toledano AY, et al. (2008) Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 359:1207–1217. doi: 10.1056/NEJMoa0800996 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kim DH, Pickhardt PJ, Taylor AJ, et al. (2007) CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 357:1403–1412. doi: 10.1056/NEJMoa070543 CrossRefPubMedGoogle Scholar
  13. 13.
    Pickhardt PJ, Choi JR, Hwang I, et al. (2003) Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 349:2191–2200. doi: 10.1056/NEJMoa031618 CrossRefPubMedGoogle Scholar
  14. 14.
    Levin B, Lieberman DA, McFarland B, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA 58:130–160. doi: 10.3322/CA.2007.0018 PubMedGoogle Scholar
  15. 15.
    Pickhardt PJ, Taylor AJ, Kim DH, et al. (2006) Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 241:417–425. doi: 10.1148/radiol.2412052007 CrossRefPubMedGoogle Scholar
  16. 16.
    Weiss JM, Smith MA, Pickhardt PJ, et al. (2013) Predictors of colorectal cancer screening variation among primary-care providers and clinics. Am J Gastroenterol 108:1159–1167. doi: 10.1038/ajg.2013.127 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Klabunde CN, Frame PS, Meadow A, et al. (2003) A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med 36:352–362CrossRefPubMedGoogle Scholar
  18. 18.
    Klabunde CN, Vernon SW, Nadel MR, et al. (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43:939–944CrossRefPubMedGoogle Scholar
  19. 19.
    Mysliwiec PA, Brown ML, Klabunde CN, et al. (2004) Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141:264–271CrossRefPubMedGoogle Scholar
  20. 20.
    Nadel MR, Shapiro JA, Kiabunde CN, et al. (2005) A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med 142:86–94CrossRefPubMedGoogle Scholar
  21. 21.
    WCHQ Wisconsin Collaborative for Healthcare Quality. http://www.wchq.org/measures/sources.php. Accessed October 19 2016
  22. 22.
    Sheehy AM, Flood GE, Tuan WJ, et al. (2010) Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc 85:27–35. doi: 10.4065/mcp.2009.0289 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Pham HH, Schrag D, O’Malley AS, et al. (2007) Care patterns in Medicare and their implications for pay for performance. N Engl J Med 356:1130–1139. doi: 10.1056/NEJMsa063979 CrossRefPubMedGoogle Scholar
  24. 24.
    Maldonado G, Greenland S (1993) Interpreting model coefficients when the true model form is unknown. Epidemiology 4:310–318CrossRefPubMedGoogle Scholar
  25. 25.
    Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control AC 19:716–723CrossRefGoogle Scholar
  26. 26.
    United States Preventive Services Task Force (2007) Guide to Clinical Preventive Services. Agency for Healthcare Research and Quality: RockvilleGoogle Scholar
  27. 27.
    Pickhardt PJ (2015) CT colonography for population screening: ready for prime time? Dig Dis Sci 60:647–659. doi: 10.1007/s10620-014-3454-2 CrossRefPubMedGoogle Scholar
  28. 28.
    Pickhardt PJ, Hanson ME, Vanness DJ, et al. (2008) Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 249:151–159. doi: 10.1148/radiol.2491072148 CrossRefPubMedGoogle Scholar
  29. 29.
    Yee J, Kumar NN, Godara S, et al. (2005) Extracolonic abnormalities discovered incidentally at CT colonography in a male population. Radiology 236:519–526. doi: 10.1148/radiol.2362040166 CrossRefPubMedGoogle Scholar
  30. 30.
    Zalis ME, Blake MA, Cai W, et al. (2012) Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med 156:692–702. doi: 10.7326/0003-4819-156-10-201205150-00005 CrossRefPubMedGoogle Scholar
  31. 31.
    Behrens C, Stevenson G, Eddy R, et al. (2010) The benefits of computed tomographic colonography in reducing a long colonoscopy waiting list. Can Assoc Radiol J 61:33–40. doi: 10.1016/j.carj.2009.09.003 CrossRefPubMedGoogle Scholar
  32. 32.
    Gluecker TM, Johnson CD, Wilson LA, et al. (2003) Extracolonic findings at CT colonography: evaluation of prevalence and cost in a screening population. Gastroenterology 124:911–916. doi: 10.1053/gast.2003.50158 CrossRefPubMedGoogle Scholar
  33. 33.
    Pooler BD, Kim DH, Pickhardt PJ (2016) Potentially important extracolonic findings at screening CT colonography: Incidence and outcomes data from a clinical screening program. Am J Roentgenol 206:313–318. doi: 10.2214/AJR.15.15193 CrossRefGoogle Scholar
  34. 34.
    Veerappan GR, Ally MR, Choi JH, et al. (2010) Extracolonic findings on CT colonography increases yield of colorectal cancer screening. Am J Roentgenol 195:677–686. doi: 10.2214/AJR.09.3779 CrossRefGoogle Scholar
  35. 35.
    Park SK, Park DI, Lee SY, et al. (2009) Extracolonic findings of computed tomographic colonography in Koreans. World J Gastroenterol 15:1487–1492CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Fichman RG, Kemerer CF (1993) Adoption of software engineering process innovations—the case of object orientation. Sloan Manag Rev 34:7–22Google Scholar
  37. 37.
    Pickhardt PJ, Hassan C, Halligan S, et al. (2011) Colorectal cancer: CT colonography and colonoscopy for detection–systematic review and meta-analysis. Radiology 259:393–405. doi: 10.1148/radiol.11101887 CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Kim DH, Matkowskyj KA, Lubner MG, et al. (2016) Serrated polyps at CT colonography: prevalence and characteristics of the serrated polyp spectrum. Radiology 280(2):455–463. doi: 10.1148/radiol.2016151608 CrossRefPubMedGoogle Scholar
  39. 39.
    Crosson FJ (2005) The delivery system matters. Health Aff (Millwood) 24(6):1543–1548. doi: 10.1377/hlthaff.24.6.1543 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Jennifer M. Weiss
    • 1
    • 6
    • 7
  • David H. Kim
    • 5
  • Maureen A. Smith
    • 2
    • 3
    • 4
    • 7
  • Aaron Potvien
    • 3
  • Jessica R. Schumacher
    • 4
  • Ronald E. Gangnon
    • 3
  • B. Dustin Pooler
    • 5
  • Patrick R. Pfau
    • 1
    • 6
  • Perry J. Pickhardt
    • 5
  1. 1.Division of Gastroenterology and HepatologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of Family MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  3. 3.Department of Population Health SciencesUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  4. 4.Department of SurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  5. 5.Department of RadiologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  6. 6.Department of MedicineUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  7. 7.University of Wisconsin Carbone Cancer CenterMadisonUSA

Personalised recommendations